(Q46150844)

19 December 2017

title

Psychiatrists' attitude towards and knowledge of clozapine treatment (English)

1 reference

19 December 2017

D Taylor

4

0 references

author name string

J Nielsen

series ordinal

1

1 reference

19 December 2017

M Dahm

series ordinal

2

1 reference

19 December 2017

H Lublin

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

22 January 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

965-971

1 reference

19 December 2017

Patients' and relatives' assessment of clozapine treatment

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Monitoring the safe use of clozapine: a consensus view from Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Comparison of clozapine use in Maryland and in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

The Efficacy of High-Dose Olanzapine Versus Clozapine in Treatment-Resistant Schizophrenia: A Double-Blind Crossover Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Psychopharmacology: Underuse of Evidence-Based Treatments in Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Low doses of clozapine may stabilize treatment-resistant bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Will routine therapeutic drug monitoring have a place in clozapine therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Long-term experience with clozapine in Denmark: research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

The clozapine access project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Clozapine alone versus clozapine and risperidone with refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Effects of family history and place and season of birth on the risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Antipsychotic polypharmacy: is there evidence for its use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

Clozapine treatment of adolescents with posttraumatic stress disorder and psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108100320

21 January 2018

Identifiers

DOI

10.1177/0269881108100320

1 reference

19 December 2017

PubMed ID

19164499

1 reference

19 December 2017